TRANS-ACPD INHIBITS CAMP FORMATION VIA A PERTUSSIS TOXIN-SENSITIVE G-PROTEIN

被引:38
作者
MANZONI, O
PREZEAU, L
SLADECZEK, F
BOCKAERT, J
机构
[1] Centre CNRS-INSERM de Pharmacologie-Endocrinologie
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1992年 / 225卷 / 04期
关键词
METABOTROPIC RECEPTOR; CAMP FORMATION; STRIATAL NEURONS;
D O I
10.1016/0922-4106(92)90112-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In primary cultured striatal neurons we found that (+/-)-trans-1-amino-cyclopentyl-1,3-dicarboxylate (trans-ACPD) could inhibit forskolin-induced cAMP formation in a dose-dependent manner (EC50 156 +/- 38-mu-M, n=5, maximal inhibition 37.8 +/- 1.2, n = 37). The trans-ACPD-induced inhibition was totally abolished in neurons preincubated with Bordetella pertussis toxin (1-mu-g/ml), demonstrating the involvement of a G-protein. This is the first report in intact neurons of a glutamate metabotropic receptor negatively coupled to cAMP formation.
引用
收藏
页码:357 / 358
页数:2
相关论文
共 7 条
[1]  
MANZONI O, 1990, MOL PHARMACOL, V38, P1
[2]   SEQUENCE AND EXPRESSION OF A METABOTROPIC GLUTAMATE RECEPTOR [J].
MASU, M ;
TANABE, Y ;
TSUCHIDA, K ;
SHIGEMOTO, R ;
NAKANISHI, S .
NATURE, 1991, 349 (6312) :760-765
[3]   METABOTROPIC EXCITATORY AMINO-ACID RECEPTORS REVEAL THEIR TRUE COLORS [J].
MILLER, RJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (10) :365-367
[4]   PHARMACOLOGICAL AND FUNCTIONAL-CHARACTERISTICS OF METABOTROPIC EXCITATORY AMINO-ACID RECEPTORS [J].
SCHOEPP, D ;
BOCKAERT, J ;
SLADECZEK, F .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (12) :508-515
[5]   A FAMILY OF METABOTROPIC GLUTAMATE RECEPTORS [J].
TANABE, Y ;
MASU, M ;
ISHII, T ;
SHIGEMOTO, R ;
NAKANISHI, S .
NEURON, 1992, 8 (01) :169-179
[6]   SYNAPTOGENESIS OF CULTURED STRIATAL NEURONS IN SERUM-FREE MEDIUM - A MORPHOLOGICAL AND BIOCHEMICAL-STUDY [J].
WEISS, S ;
PIN, JP ;
SEBBEN, M ;
KEMP, DE ;
SLADECZEK, F ;
GABRION, J ;
BOCKAERT, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (07) :2238-2242
[7]  
WEISS S, 1985, MOL PHARMACOL, V27, P595